Table 5 Electrochemical biosensor performances based on 2D MOFs.
From: 2D MOF structure, electrochemical biosensing in bioelectronic applications
2D MOF Modified Electrode | Method | Analyte | Linear Range | LOD | References |
|---|---|---|---|---|---|
2D MOFs as Non-enzymatic Electrochemical Sensors | |||||
NiCo-MOFNs | Amperometric | Glucose | 1 μM–8 mM | 0.29 μM | |
Co-MOF/GCE | Amperometric | H₂O₂ | 0.5–832.5 μM | 0.69 μM | |
Cu-TCPP/Au/p(PX)/GCE | DPV | Dopamine | 5–125 μM | 1.0 μM | |
Ni-MOF/Hemin/GCE | DPV | H₂O₂ | 1 μM–0.4 mM | 0.2 μM | |
Co-MOF/NF | Amperometric | Glucose | 0.001 mM–3 mM | 1.3 mM | |
Ni@Cu-MOF/GCE | CV | Glucose | 5 μM–2500 μM | 1.67 μM | |
2D MOFs as Electrochemical Nucleic Acid Based Biosensors | |||||
Apt/521-MOF/AE | EIS | Mucin 1 | 0.001–0.5 ng/mL | 0.12 pg/mL | |
SGC8/Zn-MOF-on-Zr-MOF/AE | EIS | PTK 7 | 0.001–1.0 ng/mL | 0.84 pg/mL | |
aptamer-BPNSs/TH/Cu-MOF/GCE | SWV | miR3123 | 2 pM–2 μM | 0.3 fM | |
Apt/Co-MOF@TPN-COF/AE | EIS | AMP | 1.0 fg/mL–1.2 ng/mL | 0.217 fg/mL | |
Ru-MOF/Fe₃O₄@SiO₂@Au | ECL | miRNA-141 | 1 fM–10 pM | 0.3 fM | |
2D MOFs as Electrochemical Immunosensors | |||||
PtNi@Cu-TCPP(Fe)-Ab₂/BSA/Ab₁/Au@MWCNTs/GCE | Amperometric | CALP | 200 fg/mL–50 ng/mL | 137.7 fg/mL | |
PEI-GO@Ab₂/Ab₁/BSA/Ag/Cu-TCPP(Fe)/MWCNTs/GCE | Amperometric | SMM | 1.186–28.051 ng/mL | 0.395 pg/mL | |
AntiSNE/Er-TAPPI/AE | EIS | NSE | 10.0 fg/mL–1.2 ng/mL | 7.1 fg/mL | |
Co/Ni MOF/luminol-AgNps | ECL | AFP | 1 pg/mL–100 ng/mL | 0.417 pg/mL |
